Screening for pancreatic cancer in familial high-risk individuals: A systematic review

World Journal of Gastroenterology

Volumn 21, Issue 28, 2015, Pages 8678-8686

  Lu, Chao ^a   Xu, Cheng Fu ^a   Wan, Xing Yong ^a   Zhu, Hua Tuo ^a   Yu, Chao Hui ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Benefit; Familial high risk individuals; Pancreatic cancer; Pancreatic tumor; Screening

Indexed keywords

ACUTE PANCREATITIS; ANXIETY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE PROCEDURE; LIFESTYLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PATIENT HISTORY OF TUMORECTOMY; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEREDITY; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

TUMOR MARKER;

BIOMARKERS, TUMOR; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEREDITY; HUMANS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84937952580     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i28.8678     Document Type: Review

References (51)

1. Pezzilli R. Screening tests for pancreatic cancer: searching for the early symptoms or the population at risk. JOP 2004; 5: 240-242 [PMID: 15254357]
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156 [PMID: 11668491]
3. Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A, Nakazawa S, Murakami K, Kakizoe T. Clinicopathologic features of small pancreatic adenocarcinoma. A collective study. Cancer 1996; 78: 986-990 [PMID: 8780535]
4. Greenhalf W, Grocock C, Harcus M, Neoptolemos J. Screening of high-risk families for pancreatic cancer. Pancreatology 2009; 9: 215-222 [PMID: 19349734 DOI: 10.1159/000210262]
5. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469 [PMID: 17872573 DOI: 10.1136/gut.2006.108456]
6. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001; 7: 738-744 [PMID: 11297271]
7. Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 2009; 8: 109-117 [PMID: 18763055 DOI: 10.1007/s10689-008-9214-8]
8. Hruban RH, Maitra A, Kern SE, Goggins M. Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007; 36: 831-849, vi [PMID: 17996793 DOI: 10.1016/j.gtc.2007.08.012]
9. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014; 12: 1495-1499 [PMID: 25046131 DOI: 10.1016/j.ijsu.2014.07.013]
10. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7: iii-x, 1-173 [PMID: 14499048]
11. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, Santaguida PL, Shamliyan T, Singh K, Tsertsvadze A, Treadwell JR. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville: MD, 2008
12. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006; 4: 766-781; quiz 665 [PMID: 16682259 DOI: 10.1016/j.cgh.2006.02.005]
13. Kim ER, Bae SY, Lee KH, Lee KT, Son HJ, Rhee JC, Lee JK. Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer? Gut Liver 2011; 5: 194-199 [PMID: 21814600 DOI: 10.5009/gnl.2011.5.2.194]
14. Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK. Variation in precursor lesions of pancreatic cancer among high-risk groups. Clin Cancer Res 2013; 19: 442-449 [PMID: 23172884 DOI: 10.1158/1078-0432.CCR-12-2730]
15. Lachter J, Cooperman JJ, Shiller M, Suissa A, Yassin K, Cohen H, Reshef R. The impact of endoscopic ultrasonography on the management of suspected pancreatic cancer - a comprehensive longitudinal continuous evaluation. Pancreas 2007; 35: 130-134 [PMID: 17632318 DOI: 10.1097/mpa.0b013e31805d8f91]
16. Zubarik R, Gordon SR, Lidofsky SD, Anderson SR, Pipas JM, Badger G, Ganguly E, Vecchio J. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study. Gastrointest Endosc 2011; 74: 87-95 [PMID: 21704809 DOI: 10.1016/j.gie.2011.03.1235]
17. Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 2009; 58: 1410-1418 [PMID: 19470496 DOI: 10.1136/gut.2008.171611]
18. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001; 1: 477-485 [PMID: 12120228 DOI: 10.1159/000055851]
19. Sud A, Wham D, Catalano M, Guda NM. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound. Pancreas 2014; 43: 458-461 [PMID: 24622079 DOI: 10.1097/mpa.0000000000000052]
20. Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg 2012; 16: 771-783 [PMID: 22127781 DOI: 10.1007/s11605-011-1781-6]
21. Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res 2010; 16: 5028-5037 [PMID: 20876795 DOI: 10.1158/1078-0432.CCR-09-3209]
22. Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009; 104: 2175-2181 [PMID: 19491823 DOI: 10.1038/ajg.2009.276]
23. Ludwig E, Olson SH, Bayuga S, Simon J, Schattner MA, Gerdes H, Allen PJ, Jarnagin WR, Kurtz RC. Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol 2011; 106: 946-954 [PMID: 21468009 DOI: 10.1038/ajg.2011.65]
24. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247-255 [PMID: 10454945]
25. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 142: 796-804; quiz e14-e15 [PMID: 22245846 DOI: 10.1053/j.gastro.2012.01.005]
26. Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer 2014; 120: 1960-1967 [PMID: 24737347 DOI: 10.1002/cncr.28662]
27. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 [PMID: 18287387 DOI: 10.3322/ca.2007.0010]
28. Larghi A, Verna EC, Lecca PG, Costamagna G. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009; 15: 1907-1914 [PMID: 19276278 DOI: 10.1158/1078-0432.ccr-08-1966]
29. Maheu C, Vodermaier A, Rothenmund H, Gallinger S, Ardiles P, Semotiuk K, Holter S, Thayalan S, Esplen MJ. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer 2010; 9: 617-624 [PMID: 20623197 DOI: 10.1007/s10689-010-9354-5]
30. Breitkopf CR, Sinicrope PS, Rabe KG, Brockman TA, Patten CA, McWilliams RR, Ehlers S, Petersen GM. Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history. Hered Cancer Clin Pract 2012; 10: 8 [PMID: 22738386 DOI: 10.1186/1897-4287-10-8]
31. Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc 2003; 57: 23-29 [PMID: 12518126 DOI: 10.1067/mge.2003.28]
32. Rubenstein JH, Scheiman JM, Anderson MA. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 2007; 7: 514-525 [PMID: 17912015 DOI: 10.1159/000108969]
33. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393: 535-545 [PMID: 18193270 DOI: 10.1007/s00423-007-0266-2]
34. La Torre G, Sferrazza A, Gualano MR, de Waure C, Clemente G, De Rose AM, Nicolotti N, Nuzzo G, Siliquini R, Boccia A, Ricciardi W. Investigating the synergistic interaction of diabetes, tobacco smoking, alcohol consumption, and hypercholesterolemia on the risk of pancreatic cancer: a case-control study in Italy. Biomed Res Int 2014; 2014: 481019 [PMID: 24877100 DOI: 10.1155/2014/481019]
35. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009; 10: 88-95 [PMID: 19111249 DOI: 10.1016/s1470-2045(08)70337-1]
36. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119: 1447-1453 [PMID: 11113065]
37. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145 [PMID: 8841182 DOI: 10.1038/ng1096-141]
38. Gorry MC, Gabbaizedeh D, Furey W, Gates LK, Preston RA, Aston CE, Zhang Y, Ulrich C, Ehrlich GD, Whitcomb DC. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997; 113: 1063-1068 [PMID: 9322498]
39. Rebours V, Boutron-Ruault MC, Schnee M, Férec C, Maire F, Hammel P, Ruszniewski P, Lévy P. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008; 103: 111-119 [PMID: 18184119 DOI: 10.1111/j.1572-0241.2007.01597.x]
40. Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809-811 [PMID: 10956390]
41. Thompson D, Easton DF. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-1365 [PMID: 12237281]
42. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, Ausems MG, Menko FH, Gomez Garcia EB, Klijn JG, Hogervorst FB, van Houwelingen JC, van't Veer LJ, Rookus MA, van Leeuwen FE. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005; 42: 711-719 [PMID: 16141007 DOI: 10.1136/jmg.2004.028829]
43. Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009; 302: 1790-1795 [PMID: 19861671 DOI: 10.1001/jama.2009.1529]
44. Murphy KM, Brune KA, Griffin C, Sollenberger JE, Petersen GM, Bansal R, Hruban RH, Kern SE. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002; 62: 3789-3793 [PMID: 12097290]
45. Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 2007; 25: 1417-1422 [PMID: 17416862 DOI: 10.1200/jco.2006.09.2452]
46. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004; 19: 182-186 [PMID: 14731128]
47. Eloubeidi MA, Chen VK, Eltoum IA, Jhala D, Chhieng DC, Jhala N, Vickers SM, Wilcox CM. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003; 98: 2663-2668 [PMID: 14687813 DOI: 10.1111/j.1572-0241.2003.08666.x]
48. Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003; 7: 118-126; discussion 127-128 [PMID: 12559193]
49. Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239: 678-685; discussion 685-687 [PMID: 15082972]
50. Tanno S, Nakano Y, Nishikawa T, Nakamura K, Sasajima J, Minoguchi M, Mizukami Y, Yanagawa N, Fujii T, Obara T, Okumura T, Kohgo Y. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008; 57: 339-343 [PMID: 17660227 DOI: 10.1136/gut.2007.129684]
51. Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess 2003; 7: 1-90 [PMID: 14670218]